论文部分内容阅读
目的观察氨溴索辅助治疗小儿支气管肺炎的疗效。方法随机选择吉林市儿童医院2007年小儿支气管肺炎应用头孢他啶患者686例,并随机分为两组。治疗组在对照组使用头孢他啶常规抗炎治疗的基础上静脉滴注盐酸氨溴索注射液辅助治疗,1次/d,疗程5～7 d。结果治疗组疗效明显高于对照组,症状及体征消失时间均比对照组明显缩短。结论氨溴索辅助治疗婴幼儿支气管肺炎疗效显著,值得临床推广使用。
Objective To observe the efficacy of ambroxol in the treatment of bronchial pneumonia in children. Methods A total of 686 cases of ceftazidime used in children with bronchopneumonia were randomly selected from Jilin Children’s Hospital in 2007 and divided into two groups at random. Treatment group in the control group using ceftazidime conventional anti-inflammatory treatment based on the intravenous infusion of ambroxol hydrochloride injection adjuvant therapy, 1 / d, treatment of 5 to 7 days. Results The treatment group was significantly higher than the control group, symptoms and signs disappeared significantly shorter than the control group. Conclusion Ambroxol has a significant therapeutic effect on bronchopneumonia in infants and young children, and is worthy of clinical promotion.